The number of deals announced in the global healthcare sector (including pharmaceuticals and medical equipment) grew by 18.1% during the week ended May 3, 2020 compared to the previous week, according to GlobalData’s deals database.

Aurojyoti Bose, Lead Analyst at GlobalData, comments: “The healthcare sector has been relatively resilient compared to other sectors and this is the third consecutive week of growth in deal activity amidst uncertainty and volatile market conditions due to the COVID-19 outbreak.”

Deal activity increased in key markets such as the US, China and the UK during the week ended May 3, 2020 compared to the previous week, while Canada and South Korea witnessed decline.

Venture financing, mergers and acquisitions (M&A), equity offerings and licensing agreement deals increased by 18.4%, 6.3%, 20.0% and 44.4%, respectively, during the week ended May 3, 2020 compared to the previous week, while partnership deal volume declined.